OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 02, 2020
More collaboration and a knowledge-based approach, driven by better analytics and high-throughput system integration, are reducing the risk of failure.
September 02, 2020
The increased use of single-use bags in biologic manufacturing poses the risk of pinholes and other defects that cannot currently be tested for.
August 07, 2020
The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.
August 02, 2020
Process modeling offers an opportunity to troubleshoot for and anticipate difficult aspects of a bioprocess.
July 31, 2020
The company has begun development of a 3D bioreactor for the cGMP production of extracellular vesicle exosomes.
July 01, 2020
Identifying the source, assessing the risk, and removing residual impurities requires a strategic approach.
June 01, 2020
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
May 20, 2020
This latest round of funding adds 14 new technology projects, workforce development, and Global Health Fund projects to NIIMBL's portfolio.
April 01, 2020
Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
The new patented process results in uniform, scalable production and the ability to deliver cell cargo similar to natural exosomes/extracellular vesicles.